M. Jørgensen

Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.

L. C. Petersen, M. Jørgensen, L. Petersen, 1983, The Biochemical journal.

Increased concentration of the fast‐acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis

M. Jørgensen, V. Bonnevie-Nielsen, Vagn Bonnevie‐Nielsen, 1987, British journal of haematology.

Splanchnic extraction and clearance of tissue plasminogen activator (t-PA) after injection of recombinant t-PA (Actilyse®) in resting healthy subjects is proportional to the arterial concentration

J. Jespersen, J. Gram, K. Tønnesen, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis.

S. Thorsen, M. Jørgensen, J. Z. Mortensen, 2009, Scandinavian journal of haematology.

Mean transit times and the sites of synthesis and catabolism of tissue plasminogen activator and plasminogen activator inhibitor type 1 in young subjects

J. Jespersen, J. Gram, K. Tønnesen, 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.

S. Thorsen, M. Jørgensen, L. Petersen, 1984, The Journal of laboratory and clinical medicine.

Plasminogen Activator Inhibitor-1 Is the Primary Inhibitor of Tissue-Type Plasminogen Activator in Pregnancy Plasma

J. Zeuthen, S. Thorsen, J. Selmer, 1987, Thrombosis and Haemostasis.

A Sensitive Solid-Phase Immunosorbent Assay for Tissue-Type Plasminogen Activator Activity in Plasma Using Trinitrobenzoylated Poly-D-Lysine as a Stimulator for Plasminogen Activation

J. Brender, S. Thorsen, P. Handest, 1987, Thrombosis and Haemostasis.

Decreased synthesis of tissue plasminogen activator antigen in users of oral contraceptives

J. Jespersen, J. Gram, K. Tønnesen, 2000 .